Nizar Abdulateef Jassim

The Effect of Vitamin D SNP FokI (rs2228570) and ApaI (rs7975232) on Axial Spondyloarthritis in Patients on Biological Treatment Open

Abdullah H. Drewil, Manal Kamal Rasheed, Nizar Abdulateef Jassim · 2025

Objective: Examine associations between FokI and ApaI genotypes and axSpA disease activity, extra‐articular manifestations (EAMs), and infliximab (INF) response in Iraqi patients. Study Design: Cross-sectional studyPlace and Duration of St…

Association of Vitamin D Receptor Gene SNP BsmI (1544410) with Axial Spondyloarthritis in Iraqi Patients Treated with Infliximab Open

Abdullah H. Drewil, Manal Kamal Rasheed, Nizar Abdulateef Jassim · 2025

Background: Axial spondyloarthritis is a chronic inflammatory disorder driven by tumor necrosis factor alpha and the interleukin-23/interleukin-17 pathway. Tumor necrosis factor alpha inhibitors such as infliximab improve outcomes, but res…

Engaging Arabic-Speaking Patients With Rheumatic Diseases Through Social Media: A Multinational Infodemiology Analysis Open

Ihsane Hmamouchi, Jean W. Liew, Nelly Ziadé, Nizar Abdulateef Jassim, Fatemah Abutiban , et al. · 2025

Anti-Carbamylated Protein Antibodies in a Sample of Iraqi Patients with Systemic Lupus Erythematosus Open

Hanan Sedeeq, Nizar Abdulateef Jassim, Leen Mustafa Kamil · 2025

Discordance between patient and physician global assessments of psoriatic arthritis activity: an observational study in 13 Arab countries Open

Noura Abbas, Ihsane Hmamouchi, Lina El Kibbi, Avin Maroof, Bassel Elzorkany , et al. · 2025

The seventh Iraqi league for bone and joint health rheumatology conference (28–30 November 2024): Opportunities, challenges, and the future Open

Asal Adnan, Ali Jawad, Nizar Abdulateef Jassim · 2025

The effect of rituximab therapy and the risk of hypogammaglobulinamea on immunoglobulin levels in patients with rheumatoid arthritis Open

Zahraa Mahdi Hamd, Nizar Abdulateef Jassim · 2024

Background. Rituximab (RTX) is a biological monoclonal antibody targeting the CD20 antigen on B cells, effectively decreasing disease activity and progression in patients with rheumatoid arthritis (RA). RTX treatment can lead to a decline …

Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis Open

Y Abbas, Nabaa Ihsan Awadh, Asal Adnan, Marwa Moayad, Ali Alkazzaz , et al. · 2024

Background: Adalimumab is approved for Rheumatoid Arthritis (RA). In 2021, A biosimilar (ABP501;Amgevita®) was licensed in Iraq. The current study aimed to ensure safety and Efficacy of Amgevita in RA Patients in Iraq. Patients and Methods…

Actual and Perceived Risk of Cardiovascular Disease among Sample of Iraqi Patients with Rheumatoid Arthritis Open

Istabraq Satam Hamoud, Nizar Abdulateef Jassim · 2024

Background: Independent of conventional risk factors, patients with rheumatoid arthritis (RA) have a significantly increased risk of cardiovascular disease (CVD). Aims of the study: To evaluate the actual and perceived 10-year CVD risk amo…

Safety of COVID-19 Vaccine in Patients with Rheumatic and Musculoskeletal Diseases Open

Ali Abdulrahman Younis, Asal Adnan Ridha, Yasameen Abbas Humadi, Nizar Abdulateef Jassim, Nabaa Ihsan Awadh , et al. · 2024

The "COVID-19" vaccination has a reassuring safety profile with no greater risk of adverse events in any specific illness or pharmacological therapy.

Actual and Perceived Risk of Cardiovascular Disease among Sample of Iraqi Patients with Rheumatoid Arthritis Open

Istabraq Satam Hamoud, Nizar Abdulateef Jassim · 2024

Background: Independent of conventional risk factors, patients with rheumatoid arthritis (RA) have a significantly increased risk of cardiovascular disease (CVD). Aims of the Study: To evaluate the actual and perceived 10-year CVD risk amo…

Patient registry data on the efficacy and tolerability of adalimumab biosimilar in ankylosing spondylitis: A retrospective multicenter observational study Open

Nabaa Ihsan Awadh, Faiq I. Gorial, Yasameen Abbas Humadi, Asal Adnan Ridha, Nizar Abdulateef Jassim , et al. · 2023

BACKGROUND: Adalimumab, a tumor necrosis factor-α inhibitor, is an approved treatment for ankylosing spondylitis (AS). In Iraq, a biosimilar of adalimumab (ABP 501; Amgevita®) has been licensed for prescription since 2021. However, there h…

ADHERENCE TO METHOTREXATE IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS : A CROSS-SECTIONAL STUDY Open

Ali M. Kadim Al-Tuma, Nizar Abdulateef Jassim · 2022

Introduction: Methotrexate (MTX) is the most widely used disease modifying anti-rheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis (RA). In RA, medication adherence is variable and sub-optimal. Poor adherence affects 20-70% …

COVID-19 AMONG A SAMPLE OF IRAQI PATIENTS WITH RHEUMATIC DISEASES: A MULTICENTER STUDY Open

Faiq I. Gorial, Ali Abdulrahman Younis, Ali Alkazzaz, Avin Maroof, Taha Ahmad Qaradaghi , et al. · 2021

Background: There are scarce data on disease characteristics and severity of coronavirus 2019 (COVID-19) among Iraqi patients with rheumatic diseases (RDs).In this study, we aimed to report the disease characteristics and variables associa…

Challenges in Applying Treat to Target Strategy in Sample of Iraqi Patients with Rheumatoid Arthritis Open

Nizar Abdulateef Jassim, Asal Adnan Redha · 2021

This study identified interruption of biologic drugs supply as a large barrier to RA treatment target. The data supported improved outcomes among patients receiving biological treatments. Additionally, certain factors were associated with …

The Assessment of Knowledge in Sample of Iraqi Patients with Ankylosing Spondylitis Open

Nizar Abdulateef Jassim, Saba Majeed · 2020

Ankylosing spondylitis (AS) is a chronic inflammatory disease of the sacroiliac joints and spine that may be associated with a variety of extra-spinal lesions. Knowledge acquisition is a complex procedure and depends on patient intelligenc…

Attitude of Iraqi Rheumatologists While Managing Rheumatic Diseases in the Era of COVID-19: An Online Survey Open

Nizar Abdulateef Jassim, Dina Yasiry, Yasameen Abbass Hummadi · 2020

Despite the lack of solid guidelines regarding the management of rheumatic diseases during the COVID-19 crisis, this survey showed the majority of Iraqi rheumatologists to be familiar with the updating recommendations. Also, as the majorit…

Prevalence of Fibromyalgia in Infertile Women Open

Nizar Abdulateef Jassim · 2019

خلفية البحث: ألم الليف العضلي هو المصطلح الحالي للألم العضلي الهيكلي المنتشر المزمن والذي ليس له سبب بديل يمكن تحديده, وهو كثيرا ما يصيب النساء بعمر الخصب. الم الليف العضلي هو متلازمة مضعفة ومحبطة تنجم دائما عن أحداث نفسية أو جسدية مجهدة. …

Prevalence of Fibromyalgia in Infertile Women Open

Russul A. Shakir, Ala H. Badr, Nizar Abdulateef Jassim, Jasmine A. Hummadi · 2019

Background: Fibromyalgia is a functional disorder of growing importance characterized by chronic widespread musculoskeletal pain. It frequently affects women of child bearing age. Infertility is failure to achieve pregnancy within a 12 mon…

The Role of Frizzled-Related Protein3 Frzb3 Gene Polymorphisms` in Iraqi Patients with Knee Osteoarthritis Open

Nadia N. Hassan, Estabraq A. Alwasiti, Nizar Abdulateef Jassim · 2019

Evaluation of the Clinical use of Metformin or Pioglitazone in Combination with Meloxicam in Patients with Knee Osteoarthritis; using Knee Injury and Osteoarthritis outcome Score Open

Mohammed M. Mohammed, Kassim J. Al-Shamma, Nizar Abdulateef Jassim · 2017

Osteoarthritis is the most prevalent arthritic disease and a leading cause of disability. The pathogenesis of osteoarthritis involves multiple etiologies, including variable degree of synovial inflammation. Metformin and pioglitazone could…

Pan Arab Osteoporosis Society Guidelines for Osteoporosis Management Open

Nizar Abdulateef Jassim, Gemma Adib, Y. Rahman, Faiq I. Gorial, Abdullah Maghraoui , et al. · 2017

Osteoporosis is the most common bone disease in humans. With its related fragility fracture, it represents a major public health problem in our region, with a significant medical and socio-economic burden. The high prevalence rate of vitam…

Serum Vitamin D Level in Behcet's Disease: Single Center Study from Iraq Open

Nizar Abdulateef Jassim, Noor Hassan A. Alrasool, Faiq I. Gorial · 2016

Background: Behcet’s disease (BD) is a multisystemic vasculitis. Low serum vitamin D status is closely associated with disease risk of BD. Objective: To evaluate serum vitamin D level in Iraqi patients with BD. Patients and methods: In thi…

Circulating Preptin as a Marker for Osteoblast Inhibition in Rheumatoid Arthritic Patients Treated with Corticosteroids Open

Hedef Dhafir El-Yassin, Shifaa Jameel Ibraheem, Nizar Abdulateef Jassim · 2016

Preptin is a newly isolated 34 amino acid peptide hormone co-secreted with insulin and amylin from pancreatic β-cells as a regulatory element in bone metabolism with an unclear yet mechanism Rheumatoid arthritis (RA) is an autoimmune dis…

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis. Open

Mohammed A. Alkarkhi, Muhammed M. Al-Ani, Nizar Abdulateef Jassim · 2015

Background: Rheumatoid arthritis is a common chronic and destructive autoimmune arthropathy .Treatment with infliximab gives great improvement to a large numbers of patients with RA ,however, in some patients after prolonged treatment infl…

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis. Open

Mohammed A. Alkarkhi, Muhammed M. Al-Ani, Nizar Abdulateef Jassim · 2015

Background: Rheumatoid arthritis is a common chronic and destructive autoimmune arthropathy .Treatment with infliximab gives great improvement to a large numbers of patients with RA ,however, in some patients after prolonged treatment infl…

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis Open

Nizar Abdulateef Jassim · 2015

Background: Since the introduction of tumour necrosis factor-alpha (TNF-α) inhibitors including etanercept, their efficacy and safety in treatment of rheumatoid arthritis (RA) have been studied in many randomized controlled clinical trials…

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis Open

Nizar Abdulateef Jassim · 2015

Background: Since the introduction of tumour necrosis factor-alpha (TNF-α) inhibitors including etanercept, their efficacy and safety in treatment of rheumatoid arthritis (RA) have been studied in many randomized controlled clinical trials…

Nizar Abdulateef Jassim YOU? Author Swipe